First, although there is a limitation in patient samples, we found that reduced neurofibromin in patient-derived NF1-associated MPNST tissues and MPNST cells are the main cause of the overexpression of EGFR. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.